- Abstract
- Core Tip
- Article Highlights
- Full Article with Cover (PDF)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (46)
- Timeline of Article Publication (3)
- Authors Evaluation (1)
- Article Quality Tracking (0)
- Reader Comments (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2892)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2021 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Surgery
ISSN
1948-9366
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hong S, Song KB, Hwang DW, Lee JH, Lee W, Jun E, Kwon J, Park Y, Park SY, Kim N, Shin D, Kim H, Sung M, Ryu Y, Kim SC. Preoperative serum carbohydrate antigen 19-9 levels predict early recurrence after the resection of early-stage pancreatic ductal adenocarcinoma. World J Gastrointest Surg 2021; 13(11): 1423-1435 [PMID: 34950431 DOI: 10.4240/wjgs.v13.i11.1423] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9366/full/v13/i11/1423.htm |
| Number | Citing Articles |
| 1 |
Taichi Terai, Minako Nagai, Kota Nakamura, Yuichiro Kohara, Satoshi Yasuda, Yasuko Matsuo, Shunsuke Doi, Takeshi Sakata, Masayuki Sho. Combination of carbohydrate antigen 19-9 level and tumor size after neoadjuvant chemoradiation therapy may predict early recurrence of resectable pancreatic ductal adenocarcinoma. Pancreatology 2023; 23(8): 970 doi: 10.1016/j.pan.2023.10.014
|
| 2 |
Zhenshan Shi, Chengle Ma, Xinming Huang, Dairong Cao. Magnetic Resonance Imaging Radiomics‐Based Nomogram From Primary Tumor for Pretreatment Prediction of Peripancreatic Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma: A Multicenter Study. Journal of Magnetic Resonance Imaging 2022; 55(3): 823 doi: 10.1002/jmri.28048
|
| 3 |
Jingjing Li, Jiadi Du, Yuying Li, Mingzhu Meng, Junjie Hang, Haifeng Shi. A nomogram based on CT texture features to predict the response of patients with advanced pancreatic cancer treated with chemotherapy. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02902-4
|
| 4 |
Barbara Wlodarczyk, Lukasz Durko, Przemyslaw Wlodarczyk, Renata Talar-Wojnarowska, Ewa Malecka-Wojciesko. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation. Journal of Clinical Medicine 2023; 12(12): 4050 doi: 10.3390/jcm12124050
|
| 5 |
Hye Yeon Chon, Hee Seung Lee, You-Na Sung, Yoo Keung Tae, Chan Hee Park, Galam Leem, So Jung Kim, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seung Woo Park, Seung-Mo Hong, Seungmin Bang. Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-52909-4
|